BTIG Maintains Buy on Liquidia, Raises Price Target to $17
BTIG analyst Julian Harrison maintains Liquidia (NASDAQ:LQDA) with a Buy and raises the price target from $14 to $17.
Citigroup Maintains Buy on Apellis Pharmaceuticals, Raises Price Target to $86
Citigroup analyst Yigal Nochomovitz maintains Apellis Pharmaceuticals (NASDAQ:APLS) with a Buy and raises the price target from $81 to $86.
Goldman Sachs Initiates Coverage On Innoviva with Neutral Rating, Announces Price Target of $16
Goldman Sachs analyst Chris Shibutani initiates coverage on Innoviva (NASDAQ:INVA) with a Neutral rating and announces Price Target of $16.
Goldman Sachs Downgrades Vasta Platform to Neutral, Announces $5.5 Price Target
Goldman Sachs analyst Diego Aragao downgrades Vasta Platform (NASDAQ:VSTA) from Buy to Neutral and announces $5.5 price target.
Citigroup Maintains Buy on WNS (Hldgs), Lowers Price Target to $91
Citigroup analyst Ashwin Shirvaikar maintains WNS (Hldgs) (NYSE:WNS) with a Buy and lowers the price target from $102 to $91.
Citigroup Maintains Buy on Genpact, Lowers Price Target to $52
Citigroup analyst Ashwin Shirvaikar maintains Genpact (NYSE:G) with a Buy and lowers the price target from $55 to $52.
JP Morgan Maintains Overweight on Coca-Cola, Lowers Price Target to $70
JP Morgan analyst Andrea Teixeira maintains Coca-Cola (NYSE:KO) with a Overweight and lowers the price target from $73 to $70.
Raymond James Maintains Outperform on Johnson & Johnson, Lowers Price Target to $192
Raymond James analyst Jayson Bedford maintains Johnson & Johnson (NYSE:JNJ) with a Outperform and lowers the price target from $196 to $192.
Raymond James Maintains Strong Buy on Hancock Whitney, Raises Price Target to $60
Raymond James analyst Michael Rose maintains Hancock Whitney (NASDAQ:HWC) with a Strong Buy and raises the price target from $58 to $60.
JP Morgan Maintains Overweight on PayPal Holdings, Lowers Price Target to $112
JP Morgan analyst Tien-Tsin Huang maintains PayPal Holdings (NASDAQ:PYPL) with a Overweight and lowers the price target from $127 to $112.